与功能障碍相关的条状直接通路神经元的过度发射由多巴胺和激发性突触输入受阻
Michael B Ryan1, Allison E Girasole1, Andrew J Flores2
1Neuroscience Graduate Program, UCSF, San Francisco, CA 94158, USA; Kavli Institute for Fundamental Neuroscience, UCSF, San Francisco, CA 94158, USA; Weill Institute for Neurosciences, UCSF, San Francisco, CA 94158, USA.
Cell reports
|July 18, 2024
概括
对帕金森病的乐沃多巴治疗可能会导致非自愿的运动 (由乐沃多巴诱导的动力障碍). 这项研究揭示了大脑条纹体中的特定神经元被差异激活,为行动选择机制提供了洞察力.
科学领域:
- 神经科学是一个神经科学.
- 细胞和分子生物学 细胞和分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 条形体对于行动选择至关重要,它集成多巴胺和谷氨酸信号.
- 了解诸如多巴诱导的运动障碍症 (LID) 这样的病态状态,可以阐明正常功能.
- LID是帕金森病治疗的常见并发症.
研究的目的:
- 调查LID.背后的细胞和突触机制.
- 为了探索如何不同的细分群体的条状直接通路中状神经元 (dMSNs) 促进行动选择.
- 为了确定驱动在LID中差异性神经元激活的因素.
主要方法:
- 在LID.的小鼠模型中使用了活动依赖工具 (FosTRAP).
- 在体内检查了功能上不同的dMSN子集.
- 分析了多巴胺受体表达,多巴胺依赖激发能力和刺激输入.
主要成果:
- 与其他dMSN相比,levodopa差异激活的运动障碍相关的dMSN (TRAPed).
- 被TRAP的dMSN表现出更高的多巴胺受体表达和多巴胺依赖的兴奋性.
- 在TRAPed dMSN中观察到来自运动皮层和丘脑的刺激输入增加.
结论:
- dMSN亚群的差异激活是由内在和突触性质驱动的.
- 这些发现表明神经元条体中神经元异质性如何支持动作选择的机制.
- 这项研究提供了关于勒沃多巴诱导的运动障碍症的病理生理学的见解.
相关概念视频
01:15Parkinson's Disease: Overview
517
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
517
01:24Parkinson's Disease: Treatment
244
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
244
01:37Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
01:29Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K
01:29Excitatory and Inhibitory Effects of Neurotransmitters
9.9K
When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of...
9.9K